Predictors of Gleason score upgrading in patients with biopsy diagnosis of grade group 1 prostate cancer
Turkish Journal of Medical Sciences · 18.02.2025 · 55 (1) · 231-236
DOI: 10.55730/1300-0144.5962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.02.2025. Verfasst von Barış Esen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Koç University, İstanbul, Turkiye. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aimTransrectal ultrasound-guided biopsy is the most commonly employed method in the diagnostic pathway of prostatic adenocarcinoma. Gleason score of the tumor is the critical tissue-based determinant of patient management after diagnosis, and main approach for low risk patients with grade group (GG) 1 disease is active surveillance rather than definitive interventions. However, a fair proportion of these cases is upgraded following radical prostatectomy (RP) if performed. We aimed to investigate the significance of clinicopathological parameters including PTEN protein in the prediction of higher final grade at radical prostatectomy in patients with biopsy diagnosis of GG1 prostatic carcinoma. Materials and methods33 patients who underwent robotic-assisted RP (RARP) for grade GG1 disease at prostate biopsy were evaluated retrospectively. Their clinical, radiological and pathological features were explored in addition to final histological grade in RP. Upgrade was defined as any increase in Gleason score from initial needle biopsy to pathological analysis of the entire surgical specimen. Expression of PTEN in prostate biopsy cores was evaluated through immunohistochemistry. Multivariate logistic regression was performed to detect independent predictors of tumor upgrading from biopsy to RP.ResultsThe final RP pathology revealed upgrading in 16 patients (48.5%) to GG2 disease. The statistics showed that PIRADS score (≤3 vs 4-5) of the index lesion and the number of involved cores in systematic biopsies (≤2 vs >2) were the only independent predictors of the presence of higher grade at RP (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, Koç University, İstanbul, Turkiye.
- Department of Radiology, Faculty of Medicine, Koç University, İstanbul, Turkiye.
- Department of Urology, VKF AmericanHospital, İstanbul, Turkiye.
- Department of Pathology, Faculty of Medicine, Koç University, İstanbul, Turkiye.
ORCID-Profile: Barış Esen, Bengi Gürses, Arif Özkan, Mert Kiliç, Yakup Kordan, Tarık Esen, Dilek Ertoy Baydar
Zitieren
APA
Esen, B., Gürses, B., Özkan, A., Kiliç, M., Kordan, Y., Esen, T., & Ertoy Baydar, D. (2025). Predictors of Gleason score upgrading in patients with biopsy diagnosis of grade group 1 prostate cancer. Turkish Journal of Medical Sciences, 55(1), 231-236. https://doi.org/10.55730/1300-0144.5962
Vancouver
Esen B, Gürses B, Özkan A, Kiliç M, Kordan Y, Esen T, et al. Predictors of Gleason score upgrading in patients with biopsy diagnosis of grade group 1 prostate cancer. Turkish Journal of Medical Sciences. 2025;55(1):231-236. doi:10.55730/1300-0144.5962
BibTeX
@article{Esen2025,
author = {Esen, Barış and Gürses, Bengi and Özkan, Arif and Kiliç, Mert and Kordan, Yakup and Esen, Tarık and Ertoy Baydar, Dilek},
title = {Predictors of Gleason score upgrading in patients with biopsy diagnosis of grade group 1 prostate cancer},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {1},
pages = {231--236},
doi = {10.55730/1300-0144.5962}
}
EUVIMED